EQUIPIN Drug Patent Profile
✉ Email this page to a colleague
When do Equipin patents expire, and when can generic versions of Equipin launch?
Equipin is a drug marketed by Mission Pharma and is included in one NDA.
The generic ingredient in EQUIPIN is homatropine methylbromide. There are five drug master file entries for this compound. Additional details are available on the homatropine methylbromide profile page.
Summary for EQUIPIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 48 |
Patent Applications: | 2 |
Formulation / Manufacturing: | see details |
DailyMed Link: | EQUIPIN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for EQUIPIN
US Patents and Regulatory Information for EQUIPIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mission Pharma | EQUIPIN | homatropine methylbromide | TABLET, CHEWABLE;ORAL | 086310-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |